Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer

NCT00135018 is registered in ClinicalTrials.gov with Organisation for Oncology and Translational Research as lead sponsor.

NCT NCT00135018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00135018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer
Lead sponsor
Organisation for Oncology and Translational Research
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
May 31, 2012
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer